Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
AR ›
ARVITA
Trademark search for:
ARVITA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-12-16 — Application filed
2012-03-13 — Sn assigned for sect 66a appl from ib
2012-03-15 — Application filed
2012-03-20 — Application filed
2012-03-25 — Assigned to examiner
2012-04-03 — Final disposition recorded
2012-04-04 — Office action issued
2012-04-06 — Office action issued
2012-04-06 — Office action issued
2012-04-27 — Office action issued
2012-05-07 — Assigned to examiner
2012-08-01 — Office action issued
2012-08-01 — Correspondence received in law office
2012-08-02 — Teas/email correspondence entered
2012-08-21 — Suspension letter written
2012-08-21 — Letter of suspension e-mailed
2012-08-21 — Notification of letter of suspension e-mailed
2013-02-21 — Assigned to lie
2013-03-07 — Report completed suspension check case still suspended
2013-08-14 — Notification of possible opposition sent to ib
2013-08-14 — Notification of possible opposition created, to be sent to ib
2013-08-30 — Notification of possible opposition - processed by ib
2013-09-19 — Report completed suspension check case still suspended
2014-03-21 — Suspension checked - to attorney for action
2014-03-24 — Approved for pub - principal register
2014-04-04 — Law office publication review completed
2014-04-23 — Notification of possible opposition sent to ib
2014-04-23 — Notification of notice of publication e-mailed
2014-04-23 — Notice of start of opposition period created, to be sent to ib
2014-05-13 — Published for opposition
2014-05-13 — Official gazette publication confirmation e-mailed
2014-06-13 — Notification processed by ib
2014-07-29 — Registered-principal register
2014-10-29 — Final disposition recorded
2014-10-30 — New representative at ib received
2015-01-15 — Final disposition recorded
2015-01-15 — Final disposition recorded
2015-01-30 — Final disposition recorded
2015-06-26 — Change of name/address rec'd from ib
2019-04-18 — Change of owner received from ib
2019-07-29 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2019-10-08 — Teas section 71 received
2020-02-19 — Case assigned to post registration paralegal
2020-02-24 — Registered-sec.71 accepted
2020-02-24 — Notice of acceptance of sec. 71 - e-mailed
2021-12-16 — Final status recorded
2022-07-10 — Death of international registration
2022-07-10 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Monopar Therapeutics Inc.
Northbrook , IL
ONXEO
FR
BIOALLIANCE PHARMA
FR
BIOALLIANCE PHARMA
FR
Correspondent
Richard M. LaBarge Marshall, Gerstein & Borun LLP 233 S. Wacker Drive Suite 6300 Chicago, IL 60606
Filing Details
Filing Date:
2011-12-16
Status Date:
2021-12-16
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.